Table 3.

Patient evaluations at 6 and 24 months after surgery: subgroup analyzes of participants whose CP “regularly” versus “rarely or never” discussed QoL-profiles with them

	6 months			24 months
	QoL-profile regularly discussed with CP (%) (n = 29)	QoL-profile rarely/never discussed with CP (%) (n = 10)	Pa	QoL-profile regularly discussed with CP (%) (n = 18)	QoL-profile rarely/never discussed with CP (%) (n = 12)	pa
The discussion of the QoL-profile with the CP was helpful	83	0	< .001	78	8	< .001
The QoL-profile comprises all dimensions that were relevant for me during the last months	66	70	.56	94	33	.01
My other needs (e.g., pain, sorrows, anxiety) were also treated in addition to the diagnosis of breast cancer	72	30	.04	94	25	< .001
My physicians and therapists found the right treatment strategy for my other needs	69	40	.23	89	17	< .001
Personal benefit by QoL measurements
I was regularly asked about my wellbeing	72	50	.25	83	50	.10
My wellbeing and QoL were more often discussed during the medical appointment	55	20	.07	61	8	.01
The communication with my CP has improved	24	0	.16	28	8	.36
The relationship with my CP has improved	24	0	.16	33	17	.42
Other benefits	21	0	.31	22	0	.13
No benefit	14	60	.01	6	77	< .001
The completion of the QoL questionnaire was burdensome	3	10	.45	6	0	1.0

^aAll p values derived from χ² tests or Fisher’s exacts test if smallest expected cell value was < 5

p values < 0.05 are presented in bold face